MRNA - Moderna, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Moderna, Inc.

200 Technology Square
Cambridge, MA 02139
United States
617-714-6500
http://www.modernatx.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees760

Key Executives

NameTitlePayExercisedYear Born
Dr. Noubar B. Afeyan Ph.D.Co-Founder, Chairman & Member of Technology Advisory Board101.27kN/A1963
Mr. Stéphane BancelCEO & Director2.67MN/A1973
Dr. Lorence H. KimChief Financial Officer1.22MN/A1974
Dr. Stephen HogePresN/AN/A1976
Jennifer LeeChief Accounting OfficerN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. As of February 15, 2019 the company had 11 programs in clinical trials and a total of 20 development candidates in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. It has strategic alliances with AstraZeneca, Merck & Co., Vertex Pharmaceuticals, Biomedical Advanced Research and Development Authority, Defense Advanced Research Projects Agency, and Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Corporate Governance

Moderna, Inc.’s ISS Governance QualityScore as of July 29, 2019 is 10. The pillar scores are Audit: 2; Board: 9; Shareholder Rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.